Edited by Ruma BanerjeePrenyltransferases of the dimethylallyltryptophan synthase (DMATS) superfamily catalyze the attachment of prenyl or prenyl-like moieties to diverse acceptor compounds. These acceptor molecules are generally aromatic in nature and mostly indole or indole-like. Their catalytic transformation represents a major skeletal diversification step in the biosynthesis of secondary metabolites, including the indole alkaloids. DMATS enzymes thus contribute significantly to the biological and pharmacological diversity of small molecule metabolites. Understanding the substrate specificity of these enzymes could create opportunities for their biocatalytic use in preparing complex synthetic scaffolds. However, there has been no framework to achieve this in a rational way. Here, we report a chemoinformatic pipeline to enable prenyltransferase substrate prediction. We systematically catalogued 32 unique prenyltransferases and 167 unique substrates to create possible reaction matrices and compiled these data into a browsable database named PrenDB. We then used a newly developed algorithm based on molecular fragmentation to automatically extract reactive chemical epitopes. The analysis of the collected data sheds light on the thus far explored substrate space of DMATS enzymes. To assess the predictive performance of our virtual reaction extraction tool, 38 potential substrates were tested as prenyl acceptors in assays with three prenyltransferases, and we were able to detect turnover in >55% of the cases. The database, PrenDB (www.kolblab.org/prendb.php), enables the prediction of potential substrates for chemoenzymatic synthesis through substructure similarity and virtual chemical transformation techniques. It aims at making prenyltransferases and their highly regio-and stereoselective reactions accessible to the research community for integration in synthetic work flows.Prenylated primary and secondary metabolites, including indole alkaloids, flavonoids, coumarins, xanthones, quinones, and naphthalenes, are widely distributed in terrestrial and marine organisms. They exhibit a wide range of biological activities, including cytotoxic, antioxidant, and antimicrobial activities (1-3). Compared with their non-prenylated precursors, these compounds usually demonstrate distinct and often improved biological and pharmacological activities, which makes them promising candidates for drug discovery and development (1, 2, 4 -6). These compounds could be considered hybrid molecules of prenyl moieties of different chain lengths (n⅐C 5 , where n is an integer number) and aromatic skeletons originating from various biosynthetic pathways (7, 8). Prenyl transfer reactions (i.e. the connections of prenyl moieties to the aromatic nucleus) are catalyzed by a diverse family of prenyltransferases. Interestingly, this step usually represents the key transformation in the biosynthesis of such compounds. A prenyl moiety can be attached by prenyltransferases via its C1 (regular prenylation) or C3 (reverse prenylation) to carbon, oxyg...